Proteasomal degradation of human peptidyl prolyl isomerase pin1-pointing phospho Bcl2 toward dephosphorylation.

[1]  L. Carpenter,et al.  PKCδ Is Required for Mitochondrial-dependent Apoptosis in Salivary Epithelial Cells* , 2001, The Journal of Biological Chemistry.

[2]  Tianhua Niu,et al.  Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c‐Jun towards cyclin D1 , 2001, The EMBO journal.

[3]  T. Hsu,et al.  Drosophila Pin1 prolyl isomerase Dodo is a MAP kinase signal responder during oogenesis , 2001, Nature Cell Biology.

[4]  M. Kirschner,et al.  Pin1 acts catalytically to promote a conformational change in Cdc25. , 2001, Molecular cell.

[5]  W. Gerald,et al.  Inactivation of the apoptosis effector Apaf-1 in malignant melanoma , 2001, Nature.

[6]  John Calvin Reed,et al.  Microtubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1. , 2001, Neoplasia.

[7]  John C. Reed,et al.  Erratum: Microtubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1 (Neoplasia (2001) 3 (550-559) , 2001 .

[8]  J. Downward,et al.  The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. , 2000, Journal of cell science.

[9]  Hui Zhang,et al.  Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E. Yazlovitskaya,et al.  Effect of Extracellular Signal-regulated Kinase on p53 Accumulation in Response to Cisplatin* , 2000, The Journal of Biological Chemistry.

[11]  G Fischer,et al.  Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. , 2000, Molecular cell.

[12]  R. Craig,et al.  Myeloid Cell Leukemia 1 Is Phosphorylated through Two Distinct Pathways, One Associated with Extracellular Signal-regulated Kinase Activation and the Other with G2/M Accumulation or Protein Phosphatase 1/2A Inhibition* , 2000, The Journal of Biological Chemistry.

[13]  A. Schnapp,et al.  Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[14]  S. Haldar,et al.  Regulation of Bcl2 phosphorylation by stress response kinase pathway. , 2000, International journal of oncology.

[15]  J. Massagué,et al.  Ubiquitin-dependent degradation of TGF-β-activated Smad2 , 1999, Nature Cell Biology.

[16]  Kazuhito Yamamoto,et al.  BCL-2 Is Phosphorylated and Inactivated by an ASK1/Jun N-Terminal Protein Kinase Pathway Normally Activated at G2/M , 1999, Molecular and Cellular Biology.

[17]  K. Lu,et al.  Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism , 1999, Cellular and Molecular Life Sciences CMLS.

[18]  K. Umezawa,et al.  Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells. , 1999, Anticancer research.

[19]  P. Dent,et al.  Loss of the bcl-2 phosphorylation loop domain increases resistance of human leukemia cells (U937) to paclitaxel-mediated mitochondrial dysfunction and apoptosis. , 1999, Biochemical and biophysical research communications.

[20]  S. Lowe,et al.  Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. , 1999, Science.

[21]  R. K Srivastava,et al.  Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Korsmeyer,et al.  Cell Death in Development , 1999, Cell.

[23]  J. Massagué,et al.  Ubiquitin-dependent degradation of TGF-beta-activated smad2. , 1999, Nature cell biology.

[24]  S. Leach,et al.  Mitotic Phosphorylation of Bcl-2 during Normal Cell Cycle Progression and Taxol-induced Growth Arrest* , 1998, The Journal of Biological Chemistry.

[25]  S. Haldar,et al.  Microtubule-damaging drugs triggered bcl2 phosphorylation-requirement of phosphorylation on both serine-70 and serine-87 residues of bcl2 protein. , 1998, International journal of oncology.

[26]  P. Dent,et al.  Effect of bryostatin 1 on taxol-induced apoptosis and cytotoxicity in human leukemia cells (U937). , 1998, Biochemical pharmacology.

[27]  J C Reed,et al.  Mitochondria and apoptosis. , 1998, Science.

[28]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[29]  C. Rudin,et al.  Bcl-xL is phosphorylated in malignant cells following microtubule disruption. , 1998, Cancer research.

[30]  R. Perez-soler,et al.  Phosphorylation of Bcl-2 Is a Marker of M Phase Events and Not a Determinant of Apoptosis* , 1998, The Journal of Biological Chemistry.

[31]  S. Korsmeyer,et al.  Involvement of Microtubules in the Regulation of Bcl2 Phosphorylation and Apoptosis through Cyclic AMP-Dependent Protein Kinase , 1998, Molecular and Cellular Biology.

[32]  C. Croce,et al.  Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells. , 1998, Cancer research.

[33]  M. Kirschner,et al.  Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. , 1997, Science.

[34]  W. May,et al.  Bcl-2 Phosphorylation Required for Anti-apoptosis Function* , 1997, The Journal of Biological Chemistry.

[35]  S. Fesik,et al.  Identification of a novel regulatory domain in Bcl‐xL and Bcl‐2 , 1997, The EMBO journal.

[36]  N. Lenka,et al.  Regulation of Murine Cytochrome Oxidase Vb Gene Expression in Different Tissues and during Myogenesis , 1997, The Journal of Biological Chemistry.

[37]  C. Croce,et al.  Bcl2 is the guardian of microtubule integrity. , 1997, Cancer research.

[38]  T. Fojo,et al.  Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. , 1997, Cancer research.

[39]  Elizabeth Yang,et al.  Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.

[40]  L. Neckers,et al.  Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. , 1996, Cancer research.

[41]  T. Hunter,et al.  A human peptidyl–prolyl isomerase essential for regulation of mitosis , 1996, Nature.

[42]  C. Croce,et al.  Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. , 1996, Cancer research.

[43]  W. B. Derry,et al.  Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. , 1996, Cancer research.

[44]  E. White,et al.  Life, death, and the pursuit of apoptosis. , 1996, Genes & development.

[45]  T. Maniatis,et al.  Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. , 1995, Genes & development.

[46]  J. Cidlowski,et al.  Cell cycle and apoptosis: Common pathways to life and death , 1995, Journal of cellular biochemistry.

[47]  C. Croce,et al.  Inactivation of Bcl-2 by phosphorylation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. Schimke,et al.  Induction of apoptosis by the anti-tubulin drug colcemid: relationship of mitotic checkpoint control to the induction of apoptosis in HeLa S3 cells. , 1994, Experimental cell research.

[49]  Z. Oltvai,et al.  Checkpoints of dueling dimers foil death wishes , 1994, Cell.

[50]  Tom Maniatis,et al.  The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB , 1994, Cell.

[51]  J. Mitchell,et al.  Cycloheximide inhibits the cytotoxicity of paclitaxel (Taxol). , 1994, Anti-cancer drugs.

[52]  C. Croce,et al.  Cellular localization of the bcl-2 protein and response to glucocorticoid stress. , 1994, Cell death and differentiation.

[53]  A. Goldberg,et al.  The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. , 1994, Cell.

[54]  M. Jordan,et al.  Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[55]  John Calvin Reed,et al.  Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. , 1993, Cancer research.

[56]  C. Thompson,et al.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.

[57]  R. Schreiber,et al.  Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.

[58]  R. Donehower,et al.  Taxol: a novel investigational antimicrotubule agent. , 1990, Journal of the National Cancer Institute.

[59]  E. Harlow,et al.  Antibodies: A Laboratory Manual , 1988 .

[60]  S. Korsmeyer,et al.  Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around Jh on chromosome 14 and near a transcriptional unit on 18 , 1985, Cell.

[61]  Y. Tsujimoto,et al.  Involvement of the bcl-2 gene in human follicular lymphoma. , 1985, Science.

[62]  P. Schiff,et al.  Taxol stabilizes microtubules in mouse fibroblast cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[63]  P. Schiff,et al.  Promotion of microtubule assembly in vitro by taxol , 1979, Nature.

[64]  A. van der Eb,et al.  Transformation of rat cells by DNA of human adenovirus 5. , 1973, Virology.

[65]  A. van der Eb,et al.  A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.